medigraphic.com

2008, Number 3

<< Back Next >>

Arch Cardiol Mex 2008; 78 (3)

Initiation mode of ventricular tachyarrhythmias in chronic Chagas’ Cardiomyopathy

Rabinovich RF, Muratore CA, Baranchuk A

Language: Spanish
References: 28
Page: 279-284
PDF size: 117.28 Kb.


ABSTRACT

Aim: The purpose of this study was to investigate the modes of initiation of malignant ventricular tachyarrhythmias in patients with Chagas´ cardiomyopathy (ChC) with an implantable cardioverter-defibrillator (ICD) through the analysis of stored intracardiac electrograms. Specifically, we analyzed the incidence of ventricular arrhythmias preceded by the short-long-short-pattern (sls). Methods: We analyzed 179 spontaneous malignant ventricular tachyarrhythmias episodes in 15 patients with Chagas’ cardiomyopathy with an ICD. The mean cycle length in normal sinus rhythm before initiation of the malignant ventricular tachyarrhythmias, the ventricular tachycardia (VT) cycle length, the prematurity ratio and the number of ventricular premature contractions (VPCs) (single, pairs or multiple) that triggered malignant ventricular tachyarrhythmias were compared between the two different initiation modes. Results: Mean age: 60.4 ± 5.7 –years-old, mean EF, 33.2 ± 8.5%, 9 men and 6 women. A sls-pattern was found in 43.5% of the malignant ventricular tachyarrhythmias. Baseline cycle length (795 ± 16 vs 788 ± 14 ms), VT cycle length (320 ± 7.7 ms vs 329 ± 5.7 ms) and prematurity ratio (0.57 ± 11 vs 0.60 ± 12) were similar between sls and non-sls-sequences. Multiple VPCs as a trigger of malignant ventricular tachyarrhythmias was significantly less often in sls-events than in non-sls events (14% vs 40%; P ‹ 0.0001). Conclusions: In this select population of patients with ChC, we observed a high prevalence of sls-pattern just before initiation of malignant ventricular tachyarrhythmias. Multiple VPCs were often associated with a non-sls trigger mode.


REFERENCES

  1. Josephson ME, Almendral JM, Buxton AE, Marchlinsky FE: Mechanisms of Ventricular Tachycardia. Circulation 1987; 75 (Suppl III): 41-7.

  2. Gomez J, Alexopoulus D, Winters S, Deshmukh P, Fuster V, Suh K: The role of silent ischemia, the arrhythmic substrate and the short-long-short sequence in the genesis of the sudden cardiac death. J Am Coll Cardiol 1989; 14: 1618-25.

  3. Pratt CM, Francis MJ, Luck JC, Wyndham CR, Miller RR, Quinones MA: Analysis of ambulatory electrocardiograms in 15 patients during spontaneous ventricular fibrillation with special reference to preceding arrhythmic events. J Am Coll Cardiol 1983; 2: 789-97.

  4. Bayes de Luna A, Coumel P, Leclercq JF: Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 1989; 117: 151-9.

  5. Roelandt J, Klootwijk P, Lubsen J, Janse MJ: Sudden death during long-term ambulatory monitoring. Eur Heart J 1984; 5: 7-20.

  6. Coumel P, Leclercq J, Maisonblanche P, Attuel P, Cauchemez B: Computerized analysis of dynamic electrocardiograms: a tool for a comprehensive electrophysiology. A description of the ATREC II system. Clin Prog 1985; 3: 181-201.

  7. Winkle R, Mead R, Ruder M: Long-term outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol 1989; 13: 1353-61.

  8. Kelly P, Cannon D, Garan H, Mirabal GS, Harthorne JW, Hurvitz RJ, et al: The automatic implantable cardioverter-defibrillator: efficacy, complications and survival in patients with VT. J Am Coll Cardiol 1988; 11: 1278-86.

  9. Marchlinsky F, Gottieb C, Sarter B: ICD data storage: value in arrhythmia management. PACE 1993; 16: 527-34.

  10. Marchlinsky F, Callans D, Gottlieb C, Schwartzmann D, Preminger M: Benefits and lessons from stored electrogram information in implantable defibrillators. J Cardiovasc Electrophysiol 1995; 6: 832-51.

  11. Hook B, Callans D, Kleinman R, Flores B, Marchlinsky F: Implantable cardioverter-defibrillator therapy in the absence of significant symptoms. Circulation 1993; 87: 1897-906.

  12. Storino R, Miles J: Enfermedad de Chagas. Storino R, Milei J Eds. Buenos Aires; Mosby-Doyma Argentina, 1994: 359-455.

  13. Muratore C, Rabinovich R, Iglesias R, González M, Darú V, Sosa Liprandi A: Implantable Cardioverter-Defibrillator in Patients with Chagas Disease: Are they Different from Patients with Coronary Disease? PACE 1997; 20(Part II): 194-197.

  14. Rabinovich R, Muratore C, Iglesias R, Gonzalez M, Darú V, Valentino M, et al: Time to First Shock in Implantable Defibrillator in Patients with Chagas Cardiomyopathy. PACE 1999; 22(Pt 2): 202-205.

  15. Leclercq J, Maisonblanche P, Gauchemez B, Coumel P: Respective role of sympathetic tone and of cardiac pauses in the genesis of 62 cases of ventricular fibrillation recorded during Holter monitoring. Eur Heart J 1988; 9: 1276-83.

  16. Zimmermann M, Maisonblanche P, Gauchemez P, Leclercq J, Coumel P: Determinants of the spontaneous ectopic activity in repetitive monomorphic idiopathic ventricular tachycardia. J Am Coll Cardiol 1986; 7: 1219-27.

  17. Han J, Moe G: Nonuniform recovery of excitability of ventricular muscle. Circ Res 1964; 54: 44-59.

  18. Denker S, Lehmann M, Mahmud R, Gilbert C, Akhtar M: Facilitation of ventricular tachycardia induction with abrupt changes in ventricular cycle length. Am J Cardiol 1984; 53: 508-15.

  19. Vassallo J, Cassidy D, Kindwall E, Marchlinsky F, Josephson M: Nonuniform recovery of excitability in the left ventricle. Circulation 1988; 78: 1365-72.

  20. Leclercq J, Potenza S, Maisonblanche P, Chastang C, Coumel P: Determinants of spontaneous occurrence of sustained monomorphic ventricular tachycardia in right ventricular dysplasia. J Am Coll Cardiol 1996; 28: 720-24.

  21. De Valais F, Muratore C, Rabinovich R, Baranchuk A, Goldsmit A, Iglesias R, et al: Modos de inicio de las taquiarritmias ventriculares en pacientes con cardiodesfibrilador implantable. Rev Arg Cardiol 2001; 69, (Supl III): 111.

  22. Meyerfeldt U, Schirdewan A, Wiedemann M, Schütt H, Zimmerman F, Luft FC, et al: The mode of onset of ventricular tachycardia. A patient-specific phenomenon. Eur Heart J 1997; 18: 1956-1965.

  23. Roelke M, Garan H, McGovern B, Ruskin J: Analysis of the initiation of spontaneous monomorphic ventricular tachycardia by stored intracardiac electrograms. J Am Coll Cardiol 1994; 23: 117-22.

  24. Amorin DS, Manco JC, Gallo Jr L, Marin Neto JA: Chagas´ heart disease as an experimental model for studies of cardiac autonomic function in man. Mayo Clinic Proc 1982; 57: 48-60.

  25. Iosa D, Dequattro V, Lee DD, Elkayam U, Caeiro T, Palmero H: Pathogenesis of cardiac neuromyophaty in Chagas´disease and the role of the autonomic nervous system. J Auton Syst 1990; 30: S83-S88.

  26. Fuenmayor AJ, Rodriguez L, Torres A, Donís J, Navas M, Fuenmayor AM, et al: Valsalva maneuver; a test of the functional state of cardiac innervations in chagasic myocarditis. Int J Cardiol 1988; 18: 351-355.

  27. Oliveira JSM: A natural human model of intrinsic heart system denervation: Chagas´cardiomyopathy. Am Heart J 1985; 110: 1092-1098.

  28. Villar JC, Peña JL, Orozco L, Vega A, León H, Contreras JP, et al: Disfunción autonómica en sujetos seropositivos para T. cruzi asintomáticos. Acta médica colombiana 1997; 22: 67-77.




2020     |     www.medigraphic.com